Meda Pharmaceuticals
23
0
0
23
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 5/100
0.0%
0 terminated/withdrawn out of 23 trials
100.0%
+13.5% vs industry average
87%
20 trials in Phase 3/4
83%
19 of 23 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (23)
Flunisolide HFA in Children With Small Airway Disease
Role: collaborator
Optimized Treatment Algorithm for Patients With Early Rheumatoid Arthritis (RA)
Role: collaborator
Safety of Astepro 0.15% Nasal Spray and Astepro 0.1% Nasal Spray in Children Ages >6 Months to <6 Years With AR
Role: lead
Safety and Efficacy Trial of Dymista Nasal Spray in Children Ages 4 to 11 With Seasonal Allergic Rhinitis (SAR)
Role: lead
A Study to Evaluate the Safety and Tolerability of a Nasal Spray to Treat Perennial Allergic Rhinitis
Role: lead
A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies
Role: lead
3 Month Safety Study of Dymista Nasal Spray and Fluticasone Propionate in Children 4-11 Years of Age With Allergic Rhinitis
Role: lead
Open Label Safety Study of Xerese Cream in the Treatment of Recurrent Herpes Labialis in Children 6-11 Years Old
Role: lead
A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies
Role: lead
Evaluating the Need for New Rhinitis Treatment
Role: collaborator
Study to Evaluate Two Formulations of Carisoprodol in Subjects With Musculoskeletal Spasm of the Lower Back
Role: lead
A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies
Role: lead
Flecainide-Short Long Study (Flec-SL)
Role: collaborator
A Study Evaluating the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies
Role: lead
A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies
Role: lead
A Study to Evaluate the Safety and Efficacy of a Nasal Spray to Treat Children With Perennial Allergic Rhinitis
Role: lead
A Study to Evaluate Two Formulations of Carisoprodol in Subjects With Musculoskeletal Spasm of the Lower Back
Role: lead
A Study to Evaluate the Safety and Efficacy of a Nasal Spray to Treat Seasonal Allergies
Role: lead
A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Perennial Allergies
Role: lead
A Study to Evaluate the Safety and Efficacy of Two Nasal Sprays to Treat Seasonal Allergies
Role: lead